Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 34.54M | 15.54% |
| Gross profit | 24.8M | 10.87% |
| Net profit | 748.84K | 132.96% |
| EBITDA | 19.42M | 10,563.07% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €922.29M |
Number of shares | 65.81M |
52-week high/low | €21.18 - €11.96 |
| Dividends | No |
Beta | 1.19 |
P/E ratio | -24.13 |
PEG ratio | -0.03 |
P/B ratio | 3.42 |
P/S ratio | 6.14 |
Company profile
MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.
| Name | GNI Group Ltd |
| CEO | Ying Luo |
| Headquarters | Tokyo,
ty China |
| Website | |
| IPO | 08/31/2007 |
| Employees | 990 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Japan Exchange Group | 2160.T |
Frankfurt | 3G6.F |
Düsseldorf | 3G6.DU |
